Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jan;37(1):e43-e44.
doi: 10.1111/jdv.18531. Epub 2022 Aug 20.

Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'

Affiliations
Multicenter Study

Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'

Fabrizio Martora et al. J Eur Acad Dermatol Venereol. 2023 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors reported no conflict of interest.

Comment on

References

    1. Avallone G, Cavallo F, Astrua C, Caldarola G, Conforti C, De Simone C, et al. Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience. J Eur Acad Dermatol Venereol. 2022. 10.1111/jdv.18386 - DOI - PMC - PubMed
    1. Potestio L, Genco L, Villani A, Marasca C, Fabbrocini G, Fornaro L, et al. Reply to 'Cutaneous adverse effects of the available COVID‐19 vaccines in India: A questionnaire‐based study' by Bawane J et al. J Eur Acad Dermatol Venereol. 2022. 10.1111/jdv.18341 - DOI - PMC - PubMed
    1. Megna M, Potestio L, Gallo L, Caiazzo G, Ruggiero A, Fabbrocini G. Reply to ‘Psoriasis exacerbation after COVID‐19 vaccination: report of 14 cases from a single centre’ by Sotiriou E et al. J Eur Acad Dermatol Venereol. 2022;36(1):e11–3. - PMC - PubMed
    1. Martora F, Picone V, Fabbrocini G, Marasca C. Hidradenitis suppurativa flares following COVID‐19 vaccination: A case series. JAAD Case Rep. 2022;23:42–5. - PMC - PubMed
    1. Martora F, Fabbrocini G, Nappa P, Megna M. Reply to 'Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2' by Solimani et al. J Eur Acad Dermatol Venereol. 2022. - PMC - PubMed